MERLION PHARMACEUTICALS PTE LTD has a total of 17 patent applications. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), United Kingdom and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are PRINCIPIA BIOPHARMA INC, SALIX PHARMACEUTICALS LTD and VERSI GROUP LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United Kingdom | 3 | |
#3 | United States | 3 | |
#4 | China | 2 | |
#5 | Germany | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Fischer Carsten | 10 |
#2 | Wohlert Sven-Eric | 10 |
#3 | Vente Andreas | 10 |
#4 | Bentley Christine | 5 |
#5 | Lückermann Mark | 4 |
#6 | Sone Hiroki | 2 |
#7 | Boyce Rustum S | 2 |
#8 | Sihombing Muhammad Sofian Asi | 2 |
#9 | Alani Laman | 2 |
#10 | Ghosh Malay | 1 |
Publication | Filing date | Title |
---|---|---|
DE102015100068A1 | FINAFLOXACIN FOR USE IN THE TREATMENT OF HARNWAY INFECTIONS | |
DE102014115951A1 | Compositions containing finafloxacin and tris | |
GB0821539D0 | Therapeutic compounds and their use | |
GB0821540D0 | Lipopeptide compounds and their use | |
GB0815962D0 | Hybrid antibacterial compounds and their use |